TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease.

TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease.

Levels of tumor necrosis factor-alpha (TNF-alpha) are increased in the brain in Alzheimer's disease (AD). The TNF-alpha/TNF-R signaling pathways involve complex interactions between several proteins, including TNF-receptor-associated factor-2 (TRAF-2). We have examined the distribution and leve...

Full description

Bibliographic Details
Main Authors:	Culpan, D, Cram, D, Chalmers, K, Cornish, A, Palmer, L, Palmer, J, Hughes, A, Passmore, P, Craig, D, Craigs, D, Wilcock, G, Kehoe, P, Love, S
Format:	Journal article
Language:	English
Published:	2009

Similar Items

TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease (vol 30, pg 1052, 2009)
by: Culpan, D, et al.
Published: (2010)

TNFR-associated factor-2 (TRAF-2) expression in Alzheimer's disease
by: Culpan, D, et al.
Published: (2004)

Erratum to "TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease" [Culpan et al. (Neurobiol Aging 2009 July;30(7):1052-60)] (DOI:10.1016/j.neurobiolaging.2007.10.014)
by: Culpan, D, et al.
Published: (2010)

APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease.
by: Chalmers, K, et al.
Published: (2004)

Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease.
by: Culpan, D, et al.
Published: (2007)

Neither sequence variation in the IL-10 gene promoter nor presence of IL-10 protein in the cerebral cortex is associated with Alzheimer's disease.
by: Culpan, D, et al.
Published: (2006)

The relationship between CAV-1 and cerebral amyloid angiopathy in Alzheimer's disease
by: Chalmers, K, et al.
Published: (2004)

Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
by: van Helmond, Z, et al.
Published: (2007)

TNFR2 increases the sensitivity of ligand-induced activation of the p38 MAPK and NF-κB pathways and signals TRAF2 protein degradation in macrophages.
by: Ruspi, G, et al.
Published: (2014)

The expression of the anti-inflammatory cytokine IL-10 in Alzheimer's disease is independent of IL-10 promoter polymorphisms
by: Culpan, D, et al.
Published: (2002)

Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.
by: Culpan, D, et al.
Published: (2003)

Contributors to white matter damage in Alzheimer's disease
by: Chalmers, K, et al.
Published: (2005)

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.
by: Miners, J, et al.
Published: (2006)

Contributors to white matter damage in the frontal lobe in Alzheimer's disease.
by: Chalmers, K, et al.
Published: (2005)

Reduced neprilysin expression in Alzheimer's disease is associated with APOE E4 and cerebral amyloid angiopathy
by: Miners, J, et al.
Published: (2006)

TNFR2: The new Treg switch?
by: Cohen, JL, et al.
Published: (2017)

Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia.
by: Barker, R, et al.
Published: (2014)

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
by: Williams, S, et al.
Published: (2005)

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease
by: Williams, S, et al.
Published: (2005)

The TNFR-I and TNFR-II loci in systemic lupus erythematosus
by: Eskdale, J, et al.
Published: (1997)

Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
by: Palmer, A, et al.
Published: (1987)

Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.
by: Kehoe, P, et al.
Published: (1996)

HLA-DR3 and DQA1*0401: possible risk factors in Alzheimer's disease
by: Culpan, D, et al.
Published: (1999)

Autolysosomal acidification impairment as a mediator for TNFR1 induced neuronal necroptosis in Alzheimer's disease
by: Asimakidou, Evridiki, et al.
Published: (2024)

APOE epsilon 4 favours vascular over parenchymal deposition of A beta protein in Alzheimer's disease
by: Chalmers, K, et al.
Published: (2002)

The cholinergic hypothesis of Alzheimer's disease: a review of progress.
by: Francis, P, et al.
Published: (1999)

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
by: Kehoe, P, et al.
Published: (2007)

The cholinergic hypothesis of Alzheimer's disease: a review of progress - Reply
by: Francis, P, et al.
Published: (1999)

The -491A/T polymorphism of the Apolipoprotein E gene is associated with the ApoEepsilon4 allele and Alzheimer's disease.
by: Ahmed, A, et al.
Published: (1999)

TNFR1 and ANKYLOSING SPONDYLITIS
by: Karaderi, T, et al.
Published: (2010)

APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
by: Chalmers, K, et al.
Published: (2003)

Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
by: Pearce, B, et al.
Published: (1984)

Determinants of protein-peptide interaction specificity in the Bcl-2 and TRAF families
by: Foight, Glenna Wink
Published: (2016)

Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis
by: Izadi, D, et al.
Published: (2019)

18 IPT terima traf cemerlang
by: Harian Metro, Hayati Ibrahoim
Published: (2010)

The renin angiotensin system in Alzheimer's disease - Do updates high-light a clinical and biological dichotomy?
by: Kehoe, P, et al.
Published: (2006)

Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease.
by: Baig, S, et al.
Published: (2005)

Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
by: Blomqvist, M, et al.
Published: (2005)

Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease.
by: Chalmers, K, et al.
Published: (2009)

Loss of perineuronal nets in Alzheimer's disease is not related to tau pathology
by: Baig, S, et al.
Published: (2004)